Production of angiogenetic factor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4529590
SERIAL NO

06453795

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A process for the production of tumor angiogenetic factor and the production of antigens from a purified angiogenetic factor is shown in the present invention. The production of tumor angiogenetic factor is accomplished by injecting a material of a suitable composition to initiate production of fluid in the cavity of a living animal by inciting an inflammatory response in the cavity tissues, which response is characterized by the production of granulation tissue comprised mostly of new capillaries. After the body cavity is partly filled with the exudate, the fluid is tapped out of the cavity and purified to yield angiogenetic factor. The production of antigens is accomplished by dissolving the purified angiogenetic factor in an equal volume of distilled water, reacting the dissolved angiogenetic factor in the distilled water with a gluteraldehyde solution for at least twelve (12) hours and lyophilizing resulting mixture for storage. Animals injected with the product produce antibodies which react with the purified angiogenetic factor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEVICE DEVELOPMENTS INC350 SOUTH CENTER STE 320 LAS VEGAS NV 89501

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
LeVeen, Eric G 321 Confederate Cir., Charleston, SC 29407 35 2632
LeVeen, Robert F 312 Lombard St., Philadelphia, PA 19147 41 3991

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation